Document is current
Any future updates will be listed below
-
Authors
Rising, Camella J. https://orcid.org/0000-0002-4099-528X
Huelsnitz, Chloe O. https://orcid.org/0000-0001-8112-5005
Shepherd, Rowan Forbes https://orcid.org/0000-0003-4510-0542
Klein, William M. P. https://orcid.org/0000-0002-8847-8193
Sleight, Alix G. https://orcid.org/0000-0001-5317-060X
Wilsnack, Catherine
Boyd, Patrick https://orcid.org/0000-0001-9950-2745
Feldman, Alexandra E. https://orcid.org/0000-0002-0500-8381
Khincha, Payal P. https://orcid.org/0000-0003-2473-7800
Werner-Lin, Allison https://orcid.org/0000-0003-3133-820X
-
Funding
Funding for this research was provided by:
National Cancer Institute
- License Information
-
More Information
Article History
Received: 12 November 2023
Accepted: 5 April 2024
First Online: 20 April 2024
Change Date: 23 October 2024
Change Type: Update
Change Details: The supplementary files has been added in the article.
Declarations
:
: All study procedures were approved by the National Institutes of Health (NIH) IRB (NIH Protocol 11-C-0255, ClinicalTrials.gov, Identifier NCT01443468). The procedures used in this study adhere to the tenets of the Declaration of Helsinki.
: Informed consent was obtained from all individual participants included in the study. Parental permission was obtained prior to enrollment of individuals under age 18. Verbal informed consent was obtained before beginning audio-recorded telephone interviews. Online informed consent was obtained prior to initiating the online survey.
: Not applicable.
: The authors have no conflicts of interest to declare.
